Discussion about this post

User's avatar
Heike Larson's avatar

A key incentive missing is lower insurance rates for people who do all the things needed to stay healthy. Like: wear a CGM, get your blood sure under control without medication via lifestyle choice > CGM cost refunded and a credit toward next year’s insurance cost. Or walk an average of 10,000 steps a day as measured by a wearable you wear >90% of all days > a 5% reduction in your insurance rate.

My understanding is that the ACA makes that practically impossible as only smoking can directly impact rates.

If people paid less in insurance if the lived healthy lifestyles then that works better align incentives!

Deb Williams's avatar

The problem is not doing it may impose a cost for others Stage 1 breast cancer may be less expensive than later stages plus the costs from mixed work.

The bar that USPTF raised that it be cost effective, have robust evidence and also be worth clinicians time was meaningful. I went thru the process for the HepC drugs. It worked - terrible proposal and good final.

This is more of a discussion for those activities that don’t meet that bar or predate that process.

We all move forward, including economics from Milton Friedman. (Aka behavioral economics is more de rigeur, it’s doctors who seem to still quote Milton not monetary experts or health economists. Although he did have useful things that speak to me about evaluating public programs and some of his monetary theory has held I suppose.)

11 more comments...

Ready for more?